Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-01-2024 | Neuroblastoma | Case report

Iobenguane/lutetium-(177Lu)-oxodotreotide

Growth hormone deficiency, TSH deficiency and lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Van Wessel K, et al. Growth hormone and TSH deficiency after [177Lu] Lu-DOTATATE therapy for pediatric neuroblastoma; description of a first case. Hormone Research in Paediatrics 96 (Suppl. 4): 120 abstr. RFC13.5, Sep 2023. Available from: URL: https://dx.doi.org/10.1159/000533803 [abstract] Van Wessel K, et al. Growth hormone and TSH deficiency after [177Lu] Lu-DOTATATE therapy for pediatric neuroblastoma; description of a first case. Hormone Research in Paediatrics 96 (Suppl. 4): 120 abstr. RFC13.5, Sep 2023. Available from: URL: https://​dx.​doi.​org/​10.​1159/​000533803 [abstract]
Metadata
Title
Iobenguane/lutetium-(177Lu)-oxodotreotide
Growth hormone deficiency, TSH deficiency and lack of efficacy
Publication date
01-01-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-52632-5

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Clozapine

Case report

Voriconazole

Case report

Elasomeran

Case report

Nivolumab

Case report

Zopiclone